Claro Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.47M Buy
3,768
+633
+20% +$642K 0.42% 53
2025
Q4
$3.37M Buy
3,135
+57
+2% +$54.5K 0.46% 45
2025
Q3
$2.35M Buy
3,078
+200
+7% +$149K 0.34% 60
2025
Q2
$2.24M Sell
2,878
-853
-23% -$663K 0.37% 57
2025
Q1
$3.08M Buy
3,731
+202
+6% +$168K 0.41% 45
2024
Q4
$2.72M Sell
3,529
-685
-16% -$567K 0.37% 51
2024
Q3
$3.73M Buy
4,214
+384
+10% +$345K 0.48% 39
2024
Q2
$3.47M Buy
3,830
+216
+6% +$173K 0.54% 34
2024
Q1
$2.81M Buy
3,614
+2,272
+169% +$1.62M 0.49% 42
2023
Q4
$782K Sell
1,342
-36
-3% -$21K 0.17% 136
2023
Q3
$740K Sell
1,378
-41
-3% -$21.1K 0.19% 129
2023
Q2
$665K Buy
1,419
+70
+5% +$29.4K 0.17% 150
2023
Q1
$463K Buy
1,349
+39
+3% +$13.2K 0.14% 188
2022
Q4
$479K Buy
1,310
+189
+17% +$67K 0.16% 162
2022
Q3
$363K Hold
1,121
0.14% 167
2022
Q2
$363K Buy
1,121
+152
+16% +$45.6K 0.14% 167
2022
Q1
$268K Hold
969
0.1% 213
2021
Q4
$268K Buy
969
+17
+2% +$4.31K 0.1% 213
2021
Q3
$220K Buy
952
+18
+2% +$4.44K 0.09% 223
2021
Q2
$214K Buy
+934
New +$188K 0.1% 217
2019
Q1
Sell
-734
Closed -$79K 605
2018
Q4
$79K Buy
+734
New +$82K 0.06% 266

Other funds holding LLY

Claro Advisors's LLY Position: Q1 2026 in Review

Claro Advisors increased its Eli Lilly (LLY) stake by 20% in Q1 2026, buying an estimated $642K and bringing the position to 3,768 shares worth $3.47M. The position accounts for 0.42% of the portfolio, ranked #53.

Claro Advisors first reported a position in LLY in Q4 2018 and has held it in 21 quarters since. The position peaked at $3.73M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Claro Advisors held 3,768 shares of Eli Lilly worth $3.47M as of Q1 2026.
  • Claro Advisors bought 633 Eli Lilly shares in Q1 2026, an estimated $642K.
  • Eli Lilly made up 0.42% of Claro Advisors's portfolio in Q1 2026, its #53 holding.
  • Claro Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 21 quarters since.
  • Claro Advisors's Eli Lilly position peaked at $3.73M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Claro Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.